• English
  • عربي / Arabic
  • മലയാളം / Malayalam

GI & HPB Oncology - FAQ

FAQ's

Gastrointestinal (GI) and Hepato-Pancreato-Biliary (HPB) cancers are cancers that affect the digestive system and related organs, including:

  • Esophagus
  • Stomach (gastric cancer)
  • Small intestine
  • Colon and rectum
  • Anal canal
  • Liver (hepatocellular carcinoma)
  • Pancreas
  • Gallbladder
  • Bile ducts (cholangiocarcinoma)

These cancers often require specialized, multidisciplinary treatment because they involve complex organs responsible for digestion, metabolism, and bile production.

Diagnosis typically involves a combination of advanced imaging, endoscopic evaluation, and biopsy for confirmation.

Common diagnostic tests include:

  • High-definition endoscopy and colonoscopy
  • Endoscopic ultrasound (EUS) for tumor staging
  • ERCP for bile duct and pancreatic evaluation
  • Contrast-enhanced CT scan and MRI

  • PET-CT for comprehensive cancer staging
  • Image-guided biopsy to confirm cancer type

Accurate staging is essential to determine the most effective treatment plan.

Treatment depends on the type, stage, and location of the cancer. Most patients require a combination of therapies, including:

  • Minimally invasive or organ-preserving surgery
  • Advanced liver, pancreas, and colorectal surgery
  • Chemotherapy, targeted therapy, and immunotherapy
  • Precision radiation therapy (IMRT, IGRT, SBRT)
  • Interventional oncology treatments such as tumor ablation and TACE 

Each case is reviewed in a multidisciplinary tumor board to create a personalized, evidence-based treatment plan aimed at preserving organ function and improving survival outcomes.

Our Doctors

View More

Real Voices That Matter